Dr. Srivalli Gopaluni, MD

Dr. Gopaluni practices at Cancer Care Northwest - HOPD in Spokane, Washington.

Dr. Gopaluni's NPI, 1427208990, was assigned on September 22, 2008. Dr. Gopaluni holds Washington license MD60263783.

Dr. Gopaluni's primary practice is Cancer Care Northwest - HOPD, at 605 E Holland Ave STE 218, Spokane, WA 99218.

Dr. Gopaluni's primary practice is Cancer Care Northwest - HOPD in Spokane, Washington. Dr. Gopaluni is also affiliated with Prov Sacred Hrt Med Ctr & Childs Hosp. The medical group on file is Cancer Care Northwest. Dmand AI also links Dr. Gopaluni to 4 more hospitals and 1 group practice or clinic, each named with a free account. Dr. Gopaluni's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gopaluni practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Gopaluni's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Gopaluni is licensed in Washington.

CMS data shows 56,320 Medicare services from Dr. Gopaluni across 46 procedure codes in 2024, for 345 Medicare patients. Medicare paid $1,022,189 for them.

CMS counts 345 Medicare patients who saw Dr. Gopaluni in 2024. The largest group is 65 to 74, with 157 patients. 72% of them have high blood pressure, and 71% have cancer. 8% are also on Medicaid. Their average risk score is 2.21, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gopaluni's median patient age at 71, with 67% women.

In 2024, Dr. Gopaluni wrote 1,107 Medicare Part D claims for 193 patients. 84% of them were for generic drugs. CMS names the drug for 885 of them, across 25 drugs with 11 or more claims each, at $873,736 in total drug cost. In 2023, CMS named 832 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Gopaluni for performance year 2024, reported as part of a group. Dr. Gopaluni accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gopaluni as offering telehealth.

Dmand AI links 5 papers to Dr. Gopaluni, published from 2011 to 2012. 2012 was the busiest year, with 3. Dr. Gopaluni's most frequent co-authors are Ajeet Gajra, MD, Preeti Chaudhary, MD and Stephen L. Graziano, MD.

CMS Open Payments shows 104 general payments to Dr. Gopaluni from 23 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 52% of the total. Novartis Pharmaceuticals Corporation paid the most, $1,767.